BPC 157 Oral Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Benefits of BPC 157: Oral vs Subcutaneous Administration Peptides, like Bio Identical Hormones, are not a magic bullet but they are pretty darn close. Over the years, we have seen them effectively heal chronic wounds, reduce joint paint and